BioMed Realty Trust, Inc. (BMR) Tops Q3 FFO by 1c; Guides FY12, FY13 FFO
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q3 FFO of $0.34, $0.01 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
